KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Other Non-Current Liabilities (2016 - 2025)

NovoCure's Other Non-Current Liabilities history spans 12 years, with the latest figure at $19000.0 for Q3 2025.

  • For Q3 2025, Other Non-Current Liabilities rose 5.56% year-over-year to $19000.0; the TTM value through Sep 2025 reached $19000.0, up 5.56%, while the annual FY2024 figure was $18000.0, 0.0% changed from the prior year.
  • Other Non-Current Liabilities for Q3 2025 was $19000.0 at NovoCure, up from $18000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $379000.0 in Q3 2021 and bottomed at $18000.0 in Q4 2023.
  • The 5-year median for Other Non-Current Liabilities is $119000.0 (2023), against an average of $112368.4.
  • The largest annual shift saw Other Non-Current Liabilities soared 125.6% in 2021 before it crashed 87.84% in 2023.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $166000.0 in 2021, then decreased by 10.84% to $148000.0 in 2022, then plummeted by 87.84% to $18000.0 in 2023, then changed by 0.0% to $18000.0 in 2024, then increased by 5.56% to $19000.0 in 2025.
  • Per Business Quant, the three most recent readings for NVCR's Other Non-Current Liabilities are $19000.0 (Q3 2025), $18000.0 (Q2 2025), and $18000.0 (Q1 2025).